semaglutide canada approves first generic version of Ozempic amid rising GLP-1 competition Canada approves generic semaglutide from

Focused on triggering fat burn for energy, especially during fasted cardio in the morning

This warning is not based on human epidemiology alone but largely originates from rodent toxicology studies , where GLP-1 receptor activation led to: Increased calcitonin secretion C-cell hyperplasia C-cell adenomas and carcinomas in rats/mice These findings have been consistently observed across multiple GLP-1 receptor agonists

Days 23 When Nausea or Fatigue May Show Up Days 2 and 3 are when some people begin to notice nausea, fatigue, or a strange I should eat, but I do not want food feeling

These changes collectively enhanced reaction speed, motor function, dynamic and static balance, gait rhythm, and overall mobility (Zanchet et al., 2025)